Wolverine Trading LLC Invests $222,000 in Option Care Health, Inc. (NASDAQ:OPCH)

Wolverine Trading LLC bought a new stake in Option Care Health, Inc. (NASDAQ:OPCH) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 7,064 shares of the company’s stock, valued at approximately $222,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Blue Trust Inc. raised its position in Option Care Health by 14.8% in the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after purchasing an additional 377 shares in the last quarter. Raymond James & Associates grew its stake in shares of Option Care Health by 49.5% in the 2nd quarter. Raymond James & Associates now owns 80,230 shares of the company’s stock valued at $2,222,000 after purchasing an additional 26,560 shares during the period. Nisa Investment Advisors LLC raised its holdings in shares of Option Care Health by 5.4% in the 2nd quarter. Nisa Investment Advisors LLC now owns 13,581 shares of the company’s stock worth $376,000 after buying an additional 690 shares in the last quarter. MeadowBrook Investment Advisors LLC lifted its position in shares of Option Care Health by 36.1% during the 2nd quarter. MeadowBrook Investment Advisors LLC now owns 6,610 shares of the company’s stock worth $183,000 after buying an additional 1,755 shares during the period. Finally, Nicholas Company Inc. boosted its stake in Option Care Health by 7.0% in the 2nd quarter. Nicholas Company Inc. now owns 234,000 shares of the company’s stock valued at $6,482,000 after buying an additional 15,320 shares in the last quarter. 98.05% of the stock is owned by institutional investors.

Option Care Health Price Performance

Shares of OPCH stock opened at $23.49 on Monday. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $34.63. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The firm’s 50 day moving average is $25.40 and its 200-day moving average is $28.46. The firm has a market capitalization of $4.00 billion, a price-to-earnings ratio of 19.74, a PEG ratio of 2.45 and a beta of 1.33.

Insider Buying and Selling

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the firm’s stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the acquisition, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.64% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

OPCH has been the subject of a number of analyst reports. Jefferies Financial Group cut Option Care Health from a “buy” rating to a “hold” rating and cut their price objective for the company from $38.00 to $26.00 in a report on Thursday, October 31st. Bank of America downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and cut their price target for the company from $43.00 to $29.00 in a report on Wednesday, October 30th. The Goldman Sachs Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. Truist Financial cut their target price on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, November 1st. Finally, JMP Securities increased their price target on Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research report on Monday, September 30th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $30.14.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.